BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dasgupta I, Chatterjee A. Recent Advances in miRNA Delivery Systems. Methods Protoc 2021;4:10. [PMID: 33498244 DOI: 10.3390/mps4010010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Banthia P, Gambhir L, Sharma A, Daga D, Kapoor N, Chaudhary R, Sharma G. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03121-6] [Reference Citation Analysis]
2 Cerqueira DM, Tayeb M, Ho J. MicroRNAs in kidney development and disease. JCI Insight 2022;7:e158277. [DOI: 10.1172/jci.insight.158277] [Reference Citation Analysis]
3 Kornmueller K, Amri E, Scheideler M, Prassl R. Delivery of miRNAs to the adipose organ for metabolic health. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114110] [Reference Citation Analysis]
4 Marini F, Brandi ML. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy. Int J Mol Sci 2021;22:7352. [PMID: 34298972 DOI: 10.3390/ijms22147352] [Reference Citation Analysis]
5 Puhl DL, Mohanraj D, Nelson DW, Gilbert RJ. Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114161] [Reference Citation Analysis]
6 Orlandella FM, Auletta L, Greco A, Zannetti A, Salvatore G. Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review. Cancers (Basel) 2021;13:6020. [PMID: 34885130 DOI: 10.3390/cancers13236020] [Reference Citation Analysis]
7 Khazaei-Poul Y, Shojaei S, Koochaki A, Ghanbarian H, Mohammadi-Yeganeh S. Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells. Life Sci 2021;286:120015. [PMID: 34614416 DOI: 10.1016/j.lfs.2021.120015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Z, Shen W, Liu W, Lyu L. Role of miRNAs in melanin metabolism: Implications in melanin-related diseases. J Cosmet Dermatol 2022. [PMID: 35041756 DOI: 10.1111/jocd.14762] [Reference Citation Analysis]
9 Hadjiargyrou M. What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery In Vivo? Nucleic Acid Ther 2021. [PMID: 33960839 DOI: 10.1089/nat.2021.0013] [Reference Citation Analysis]
10 Chong ZX, Yeap SK, Ho WY, Fang CM. Unveiling the tumour-regulatory roles of miR-1275 in cancer. Pathol Res Pract 2021;230:153745. [PMID: 34953353 DOI: 10.1016/j.prp.2021.153745] [Reference Citation Analysis]
11 Beizavi Z, Gheibihayat SM, Moghadasian H, Zare H, Yeganeh BS, Askari H, Vakili S, Tajbakhsh A, Savardashtaki A. The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy? Mol Biol Rep 2021;48:5707-22. [PMID: 34275112 DOI: 10.1007/s11033-021-06547-y] [Reference Citation Analysis]
12 Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kota P. Sustained inhibition of ENaC in CF: Potential RNA-based therapies for mutation-agnostic treatment. Curr Opin Pharmacol 2022;64:102209. [PMID: 35483215 DOI: 10.1016/j.coph.2022.102209] [Reference Citation Analysis]
14 Rizzuti M, Melzi V, Gagliardi D, Resnati D, Meneri M, Dioni L, Masrori P, Hersmus N, Poesen K, Locatelli M, Biella F, Silipigni R, Bollati V, Bresolin N, Comi GP, Van Damme P, Nizzardo M, Corti S. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes. Cell Mol Life Sci 2022;79:189. [PMID: 35286466 DOI: 10.1007/s00018-022-04217-1] [Reference Citation Analysis]
15 Onishchenko A, Myasoedov V, Yefimova S, Nakonechna O, Prokopyuk V, Butov D, Kökbaş U, Klochkov V, Maksimchuk P, Kavok N, Tkachenko A. UV Light-Activated GdYVO4:Eu3+ Nanoparticles Induce Reactive Oxygen Species Generation in Leukocytes Without Affecting Erythrocytes In Vitro. Biol Trace Elem Res 2021. [PMID: 34386912 DOI: 10.1007/s12011-021-02867-z] [Reference Citation Analysis]
16 Fernandes M, Marques H, Teixeira AL, Medeiros R. miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine. Cancers 2021;13:6324. [DOI: 10.3390/cancers13246324] [Reference Citation Analysis]
17 Ortega MA, Alvarez-Mon MA, García-Montero C, Fraile-Martinez O, Lahera G, Monserrat J, Muñoz-Merida L, Mora F, Rodríguez-Jiménez R, Fernandez-Rojo S, Quintero J, Álvarez-Mon M. MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective. Biomedicines 2021;9:1659. [PMID: 34829888 DOI: 10.3390/biomedicines9111659] [Reference Citation Analysis]
18 Wonnacott A, Denby L, Jm Coward R, Fraser DJ, Bowen T. MicroRNAs and Their Delivery in Diabetic Fibrosis. Adv Drug Deliv Rev 2021;:114045. [PMID: 34767865 DOI: 10.1016/j.addr.2021.114045] [Reference Citation Analysis]
19 Lu J, Zhang Y, Liang J, Diao J, Liu P, Zhao H. Role of Exosomal MicroRNAs and Their Crosstalk with Oxidative Stress in the Pathogenesis of Osteoporosis. Oxid Med Cell Longev 2021;2021:6301433. [PMID: 34336108 DOI: 10.1155/2021/6301433] [Reference Citation Analysis]
20 Manikkath J, Jishnu PV, Wich PR, Manikkath A, Radhakrishnan R. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine (Lond) 2022. [PMID: 35014880 DOI: 10.2217/nnm-2021-0381] [Reference Citation Analysis]
21 Gelaw TA, Sanan-mishra N. Nanomaterials coupled with microRNAs for alleviating plant stress: a new opening towards sustainable agriculture. Physiol Mol Biol Plants. [DOI: 10.1007/s12298-022-01163-x] [Reference Citation Analysis]
22 Gandhi G, Abdullah S, Foead AI, Yeo WWY. The potential role of miRNA therapies in spinal muscle atrophy. J Neurol Sci 2021;427:117485. [PMID: 34015517 DOI: 10.1016/j.jns.2021.117485] [Reference Citation Analysis]
23 Mosca L, Vitiello F, Borzacchiello L, Coppola A, Tranchese RV, Pagano M, Caraglia M, Cacciapuoti G, Porcelli M. Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities. Cancers (Basel) 2021;13:3264. [PMID: 34209866 DOI: 10.3390/cancers13133264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Anthony K. RNA-based therapeutics for neurological diseases. RNA Biol 2022;19:176-90. [PMID: 35067193 DOI: 10.1080/15476286.2021.2021650] [Reference Citation Analysis]
25 Johansson K, Woodruff PG, Ansel KM. Regulation of airway immunity by epithelial miRNAs. Immunol Rev 2021. [PMID: 34549450 DOI: 10.1111/imr.13028] [Reference Citation Analysis]
26 Dubey SR, Ashavaid TF, Abraham P, Paradkar MU. Factors influencing circulating microRNAs as biomarkers for liver diseases. Mol Biol Rep. [DOI: 10.1007/s11033-022-07170-1] [Reference Citation Analysis]
27 Xie X, Guo LW, Craig Kent K. miR548ai antagonism attenuates exosome-induced endothelial cell dysfunction. Cell Death Discov 2021;7:318. [PMID: 34711811 DOI: 10.1038/s41420-021-00720-9] [Reference Citation Analysis]
28 Chong ZX, Yeap SK, Ho WY. Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma. Pharmacol Res 2021;172:105818. [PMID: 34400316 DOI: 10.1016/j.phrs.2021.105818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Momin MY, Gaddam RR, Kravitz M, Gupta A, Vikram A. The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells 2021;10:3097. [PMID: 34831320 DOI: 10.3390/cells10113097] [Reference Citation Analysis]
30 Ghafouri-Fard S, Shaterabadi D, Abak A, Shoorei H, Bahroudi Z, Taheri M, Mousavinejad SA. An update on the role of miR-379 in human disorders. Biomed Pharmacother 2021;139:111553. [PMID: 33845370 DOI: 10.1016/j.biopha.2021.111553] [Reference Citation Analysis]
31 Li Y, Chen G, He Y, Yi C, Zhang X, Zeng B, Huang Z, Deng F, Yu D. Selenomethionine-Modified Polyethylenimine-Based Nanoparticles Loaded with miR-132-3p Inhibitor-Biofunctionalized Titanium Implants for Improved Osteointegration. ACS Biomater Sci Eng 2021;7:4933-45. [PMID: 34583510 DOI: 10.1021/acsbiomaterials.1c00880] [Reference Citation Analysis]
32 Lieu CV, Loganathan N, Belsham DD. Mechanisms Driving Palmitate-Mediated Neuronal Dysregulation in the Hypothalamus. Cells 2021;10:3120. [PMID: 34831343 DOI: 10.3390/cells10113120] [Reference Citation Analysis]
33 Papukashvili D, Rcheulishvili N, Liu C, Xie F, Tyagi D, He Y, Wang PG. Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells 2021;10:2957. [PMID: 34831180 DOI: 10.3390/cells10112957] [Reference Citation Analysis]
34 Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 2022:S0168-9525(22)00018-X. [PMID: 35303998 DOI: 10.1016/j.tig.2022.02.006] [Reference Citation Analysis]
35 Taefehshokr S, Parhizkar A, Hayati S, Mousapour M, Mahmoudpour A, Eleid L, Rahmanpour D, Fattahi S, Shabani H, Taefehshokr N. Cancer immunotherapy: Challenges and limitations. Pathol Res Pract 2021;229:153723. [PMID: 34952426 DOI: 10.1016/j.prp.2021.153723] [Reference Citation Analysis]
36 Salas-huenuleo E, Hernández A, Lobos-gonzález L, Polakovičová I, Morales-zavala F, Araya E, Celis F, Romero C, Kogan MJ. Peptide Targeted Gold Nanoplatform Carrying miR-145 Induces Antitumoral Effects in Ovarian Cancer Cells. Pharmaceutics 2022;14:958. [DOI: 10.3390/pharmaceutics14050958] [Reference Citation Analysis]
37 Monaghan TM, Polytarchou C, Kao D, Alexander C, Gurnani P. Therapeutic potential of miRNAs in Clostridioides difficile infection. Future Microbiol 2022. [PMID: 35172603 DOI: 10.2217/fmb-2021-0311] [Reference Citation Analysis]
38 Bazrgar M, Khodabakhsh P, Prudencio M, Mohagheghi F, Ahmadiani A. The role of microRNA-34 family in Alzheimer's disease: A potential molecular link between neurodegeneration and metabolic disorders. Pharmacol Res 2021;172:105805. [PMID: 34371173 DOI: 10.1016/j.phrs.2021.105805] [Reference Citation Analysis]
39 Zhou J, Liu J, Gao Y, Shen L, Li S, Chen S. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Front Pharmacol 2021;12:707776. [PMID: 34305614 DOI: 10.3389/fphar.2021.707776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives. Mol Neurodegener 2021;16:76. [PMID: 34742333 DOI: 10.1186/s13024-021-00496-7] [Reference Citation Analysis]
41 Monaco F, De Conti L, Vodret S, Zanotta N, Comar M, Manzotti S, Rubini C, Graciotti L, Fulgenzi G, Bovenzi M, Baralle M, Tomasetti M, Santarelli L. Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killing. Transl Oncol 2022;20:101400. [PMID: 35334283 DOI: 10.1016/j.tranon.2022.101400] [Reference Citation Analysis]